These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8915491)

  • 1. Higher expression of oncoproteins c-myc, c-erb B-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors.
    Yang JL; Ow KT; Russell PJ; Ham JM; Crowe PJ
    Ann Surg Oncol; 1996 Nov; 3(6):574-9. PubMed ID: 8915491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proliferating cell nuclear antigen (PCNA) in relation to ras, c-erbB-2,p53, clinico-pathological variables and prognosis in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Stål O; Zhang H; Nordenskjöld B
    Int J Cancer; 1996 Feb; 69(1):5-8. PubMed ID: 8600060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.
    Saegusa M; Takano Y; Kishimoto H; Wakabayashi G; Nohga K; Okudaira M
    J Cancer Res Clin Oncol; 1993; 119(12):737-44. PubMed ID: 8104947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic markers of survival and liver recurrence after resection of liver metastases from colorectal cancer.
    Crowe PJ; Yang JL; Berney CR; Erskine C; Ham JM; Fisher R; Russell PJ
    World J Surg; 2001 Aug; 25(8):996-1001. PubMed ID: 11571982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of HER-2/neu, c-myc amplification and p53 inactivation by FISH in Egyptian patients with breast cancer.
    Ismail MF; Aly MS; Khaled HM; Mohamed HM
    Ger Med Sci; 2009 May; 7():Doc03. PubMed ID: 19675743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpression of Bcl-2, c-Myc, and p53 oncoproteins as prognostic discriminants in patients with colorectal carcinoma.
    Bhatavdekar JM; Patel DD; Ghosh N; Chikhlikar PR; Trivedi TI; Suthar TP; Doctor SS; Shah NG; Balar DB
    Dis Colon Rectum; 1997 Jul; 40(7):785-90. PubMed ID: 9221853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogene expression in gastroenteropancreatic neuroendocrine tumors: implications for pathogenesis.
    Wang DG; Johnston CF; Buchanan KD
    Cancer; 1997 Aug; 80(4):668-75. PubMed ID: 9264349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proliferating cell nuclear antigen and p53 protein expression in submucosal invasive colorectal carcinoma].
    Kanazawa Y; Onda M; Tanaka N; Seya T
    J Nippon Med Sch; 2000 Aug; 67(4):242-9. PubMed ID: 10938592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53, c-myc p62 and proliferating cell nuclear antigen (PCNA) expression in non-Hodgkin's lymphomas.
    Korkolopoulou P; Oates J; Kittas C; Crocker J
    J Clin Pathol; 1994 Jan; 47(1):9-14. PubMed ID: 7907610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53, Bcl-2 and C-Myc expressions in colorectal carcinoma associated with schistosomiasis in Egypt.
    Zalata KR; Nasif WA; Ming SC; Lotfy M; Nada NA; El-Hak NG; Leech SH
    Cell Oncol; 2005; 27(4):245-53. PubMed ID: 16308474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical detection of p21ras, c-myc and p53 oncoproteins in hepatocellular carcinoma and in non-neoplastic liver tissue].
    Pannain VL; Bottino AC; Santos RT; Coelho HS; Ribeiro-Filho J; Alves VA
    Arq Gastroenterol; 2004; 41(4):225-8. PubMed ID: 15806265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of c-erbB-2 and p53 in colorectal adenocarcinoma.
    Sun XF; Carstensen JM; Nordenskjöld B
    Anal Cell Pathol; 1995 Apr; 8(3):203-11. PubMed ID: 7547494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
    Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
    Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein markers in colorectal cancer: predictors of liver metastasis.
    Berney CR; Fisher RJ; Yang J; Russell PJ; Crowe PJ
    Ann Surg; 1999 Aug; 230(2):179-84. PubMed ID: 10450731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic dissimilarity between primary colorectal carcinomas and their lymph node metastases: ploidy, p53, bcl-2, and c-myc expression--a pilot study.
    Zalata KR; Elshal MF; Foda AA; Shoma A
    Tumour Biol; 2015 Aug; 36(8):6579-84. PubMed ID: 25840688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenes and male breast carcinoma: c-erbB-2 and p53 coexpression predicts a poor survival.
    Pich A; Margaria E; Chiusa L
    J Clin Oncol; 2000 Aug; 18(16):2948-56. PubMed ID: 10944127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical study of PCNA, EGFR, c-erbB-2 and p53 in carcinomas of large intestine].
    Yamagiwa H; Onishi N; Onishi T; Onishi T; Onishi H; Watanabe K; Kadowaki Y; Nishii M; Kato Y
    Rinsho Byori; 1995 Jul; 43(7):703-7. PubMed ID: 7674543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.